| Multicenter study on self‐medication and self‐prescription in six Latin American countries Drug Utilization Research Group, Latin America, ... Clinical Pharmacology & Therapeutics 61 (4), 488-493, 1997 | 150 | 1997 |
| Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs: a report from the Spanish System of Pharmacovigilance, including an early analysis of … A Figueras, D Capella, JM Castel, JR Laporte European journal of clinical pharmacology 47, 297-303, 1994 | 95 | 1994 |
| Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads JM Castel, A Figueras, C Pedrós, JR Laporte, D Capella Drug safety 26, 1049-1055, 2003 | 79 | 2003 |
| Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine D Capellà, JR Laporte, JM Castel, C Tristan, A Cos, FJ Morales-Olivas BMJ: British Medical Journal 297 (6650), 722, 1988 | 71 | 1988 |
| El médico ante la automedicación JR Laporte, JM Castel Medicina clínica 99, 414-414, 1992 | 52 | 1992 |
| Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter A double-blind, randomized, placebo-controlled trial: A double … M Villardell, D Sabat, JA Arnaiz, MJ Bleda, JM Castel, JR Laporte, ... European journal of clinical pharmacology 54, 917-921, 1999 | 44 | 1999 |
| Gemfibrozil-induced impotence A Figueras, JM Castel, JR Laporte, D Capellà Annals of Pharmacotherapy 27 (7-8), 982-982, 1993 | 16 | 1993 |
| The physician and self medication JR Laporte, JM Castel Medicina Clinica 99 (11), 414-416, 1992 | 16 | 1992 |
| The internet as a tool in clinical pharmacology JM Castel, A Figueras, JM Vigo British journal of clinical pharmacology 61 (6), 787-790, 2006 | 15 | 2006 |
| The DEC-net European register of paediatric drug therapy trials: contents and context C Pandolfini, M Bonati, V Rossi, E Santoro, I Choonara, C Naylor, ... European journal of clinical pharmacology 64, 611-617, 2008 | 13 | 2008 |
| Rifampicin lowers plasma concentrations of propafenone and its antiarrhythmic effect JM Castel, E Cappiello, D Leopaldi, R Latini British journal of clinical pharmacology 30 (1), 155, 1990 | 13 | 1990 |
| Identification of propafenone metaboliser phenotype from plasma and urine excretion data R Latini, M Belloni, R Bernasconi, E Cappiello, P Giani, M Landolina, ... European journal of clinical pharmacology 42, 111-114, 1992 | 12 | 1992 |
| A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias ANTTARRHYTHMIC DRUG EVALUATION GROUP (ADEG) European Heart Journal 13 (9), 1251-1258, 1992 | 10 | 1992 |
| Analgesics in the postoperative period of abdominal interventions. The Study Group on Postoperative Analgesia of the Spanish Society of Clinical Pharmacology C Aguilera, JM Arnau, C Bosch, JM Castel, JR Laporte, I Paredes, ... Medicina clínica 108 (4), 136-140, 1997 | 9 | 1997 |
| The evolution of use of anti-Parkinson drugs in Spain E Montane, A Vallano-Ferraz, JM Castel Revista de neurologia 34 (7), 612-617, 2002 | 6 | 2002 |
| Grupo de Estudio sobre la Analgesia Postoperatoria de la Sociedad Española de Farmacología Clínica C Aguilera, JM Arnau, C Bosch, JM Castel, JR Laporte, I Paredes Med Clin (Barc) 108, 136-140, 1997 | 4 | 1997 |
| Spontaneous reporting of adverse drug reactions to NSAID. A report from the Spanish system of pharmacovigilance, including an early analysis of topical and enteric coated … A Figueras, D Capella, JM Castel, JR Laorte Eur. J. Clin. Pharmacol 47, 297-303, 1994 | 4 | 1994 |
| Evolución del consumo de fármacos antiparkinsonianos en España E Montané, A Vallano Ferraz, JM Castel Revista de Neurologia, 2002, vol. 34, num. 7, p. 612-617, 2002 | 3 | 2002 |
| Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs A Figureras, D Capella, JM Castel, JR Laporte Eur J Clin Pharmacol 47, 297-303, 1994 | 3 | 1994 |
| Ocho años del programa de notificación espontánea en España: una perspectiva D Capellà, A Figueras, JM Castel, JR Laporte La farmacovigilancia en España, 35-44, 1992 | 3 | 1992 |
Albert FiguerasAssociate Professor of Clinical PharmacologyZweryfikowany adres z icf.uab.es